- Previous Close
661.60 - Open
658.70 - Bid 652.55 x --
- Ask 657.60 x --
- Day's Range
641.00 - 665.00 - 52 Week Range
350.02 - 668.00 - Volume
29,638 - Avg. Volume
19,291 - Market Cap (intraday)
263.131B - Beta (5Y Monthly) -0.09
- PE Ratio (TTM)
79.52 - EPS (TTM)
8.27 - Earnings Date Nov 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
741.92
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, Alzheimer's, bone, joint center specialties, and others. In addition, the company provides medical procedures for aneurysm, ankle arthritis and total ankle replacement, anterior cervical discectomy and fusion surgery, anterior resection, aortic aneurysm, aortic stent graft, aortic valve replacement, arthroscopy, atrial septal defect, bariatric surgery, and others. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.
www.kimshospitals.com5,013
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: KIMS.BO
View MorePerformance Overview: KIMS.BO
Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KIMS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KIMS.BO
View MoreValuation Measures
Market Cap
264.73B
Enterprise Value
281.15B
Trailing P/E
79.90
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.87
Price/Book (mrq)
13.22
Enterprise Value/Revenue
10.49
Enterprise Value/EBITDA
39.08
Financial Highlights
Profitability and Income Statement
Profit Margin
12.25%
Return on Assets (ttm)
8.48%
Return on Equity (ttm)
16.67%
Revenue (ttm)
27.05B
Net Income Avi to Common (ttm)
3.31B
Diluted EPS (ttm)
8.27
Balance Sheet and Cash Flow
Total Cash (mrq)
902M
Total Debt/Equity (mrq)
78.07%
Levered Free Cash Flow (ttm)
-2.62B